Dr. Cathy Burnweit, MD

NPI: 1720007586
Total Payments
$13,993
2023 Payments
$70.03
Companies
6
Transactions
10

Payment Breakdown by Category

Research$13,703 (97.9%)
Food & Beverage$289.90 (2.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $13,703 6 97.9%
Food and Beverage $289.90 4 2.1%

Payments by Type

Research
$13,703
6 transactions
General
$289.90
4 transactions

Top Paying Companies

Company Total Records Latest Year
VistaPharm, Inc. $6,852 3 $0 (2019)
LeHigh Valley Technologies $6,284 2 $0 (2018)
Genus Lifesciences, Inc $568.00 1 $0 (2019)
Zimmer Biomet Holdings, Inc. $119.30 2 $0 (2021)
QOL Medical, LLC $100.57 1 $0 (2017)
Medtronic, Inc. $70.03 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $70.03 1 Medtronic, Inc. ($70.03)
2021 $104.22 1 Zimmer Biomet Holdings, Inc. ($104.22)
2019 $1,151 3 Genus Lifesciences, Inc ($568.00)
2018 $7,455 2 LeHigh Valley Technologies ($3,728)
2017 $5,213 3 LeHigh Valley Technologies ($2,556)

All Payment Transactions

10 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
03/06/2023 Medtronic, Inc. SIGNIA (Device) Food and Beverage In-kind items and services $70.03 General
Category: Surgical Stapling
12/20/2021 Zimmer Biomet Holdings, Inc. SternaLock Blu (Device) Food and Beverage In-kind items and services $104.22 General
Category: CMF & Thoracic
06/11/2019 Zimmer Biomet Holdings, Inc. Pectus Bar (Device) Food and Beverage In-kind items and services $15.08 General
Category: CMF & Thoracic
01/23/2019 Genus Lifesciences, Inc Cash or cash equivalent $568.00 Research
Study: PREA Oxycodone
01/23/2019 VistaPharm, Inc. Cash or cash equivalent $568.00 Research
Study: PREA Oxycodone
01/03/2018 LeHigh Valley Technologies Cash or cash equivalent $3,727.50 Research
Study: Protocol 2012-O004
01/03/2018 VistaPharm, Inc. Cash or cash equivalent $3,727.50 Research
Study: Protocol 2012-O004
11/15/2017 LeHigh Valley Technologies Oxycodone Oral Solution (Drug) Cash or cash equivalent $2,556.00 Research
Study: PREA Study • Category: Pain
11/15/2017 VistaPharm, Inc. Cash or cash equivalent $2,556.00 Research
Study: Oxycodone PREA Study
01/19/2017 QOL Medical, LLC Sucraid (Drug) Food and Beverage Cash or cash equivalent $100.57 General
Category: THERAPY FOR CSID

Research Studies & Clinical Trials

Study Name Company Amount Records
Protocol 2012-O004 LeHigh Valley Technologies $3,728 1
Protocol 2012-O004 VistaPharm, Inc. $3,728 1
Oxycodone PREA Study VistaPharm, Inc. $2,556 1
PREA Study LeHigh Valley Technologies $2,556 1
PREA Oxycodone Genus Lifesciences, Inc $568.00 1
PREA Oxycodone VistaPharm, Inc. $568.00 1

About Dr. Cathy Burnweit, MD

Dr. Cathy Burnweit, MD is a Pediatric Surgery healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720007586.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cathy Burnweit, MD has received a total of $13,993 in payments from pharmaceutical and medical device companies, with $70.03 received in 2023. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "" ($13,703).

Practice Information

  • Specialty Pediatric Surgery
  • Location Miami, FL
  • Active Since 07/19/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 2086S0120X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1720007586

Products in Payments

  • Oxycodone Oral Solution (Drug) $2,556
  • SternaLock Blu (Device) $104.22
  • Sucraid (Drug) $100.57
  • SIGNIA (Device) $70.03
  • Pectus Bar (Device) $15.08

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Surgery Doctors in Miami